glp 1 gip triple agonist retatrutide glp-1 glucagon receptor Sweet Temptation, bitter Truth: Diabetes in the Research Spotlight Upcoming wave of hormone-based therapies
Description
doi: 10.1177/20420188231222367 11 MadsenMSAHolmJBPallejAWismannPFabriciusKRigboltKet al
Zhao T, Chen H, Cheng C, et al
The purpose is educational, and there is typically no formal testimony or cross-examination
He J, Kang Y, Lian C, Wu J, Zhou H, Ye X
While initial animal studies demonstrated a potential biological mechanism for increased risk of PDAC, this has not been observed in humans to date
